Sunshine Biopharma Inc. (SBFMW)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.22

45.10%

Pre-market Dec 13, 2024, 11:49 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07
Revenue	24.09M	4.35M	228.43K	71.41K	21.12K	447.20K	-	-	1.71K	-	-	-	-	-	-	-	-
Cost of Revenue	15.75M	2.65M	117.83K	25.85K	11.05K	391.08K	6.63K	60.73K	384.58K	263.33K	475.00K	250.00K	-	-	-	-	-
Gross Profit	8.34M	1.70M	110.60K	45.56K	10.07K	56.12K	-6.63K	-60.73K	-382.87K	-263.33K	-475.00K	-250.00K	-	-	-	-	-
Operating Income	-4.79M	-8.67M	-2.44M	-576.87K	-641.64K	-1.17M	-857.19K	-993.11K	-780.28K	-1.76M	-1.94M	-706.68K	-556.20K	-537.38K	-15.65K	-26.08K	-13.12K
Interest Income	811.97K	518.65K	328.82K	168.10K	115.90K	-	-	-	-	-	-	-	-	-	-	-	-
Pretax Income	-4.11M	-26.51M	-12.44M	-2.78M	-1.08M	-2.16M	-1.04M	-3.50M	-1.65M	-1.93M	-2.49M	-707.95K	-	-537.38K	-	-	-
Net Income	-4.51M	-26.74M	-12.77M	-897.68K	-1.46M	-2.16M	-1.04M	-3.50M	-1.65M	-1.93M	-2.49M	-707.95K	-556.20K	-537.38K	-	-31.11K	-13.12K
Selling & General & Admin	10.83M	9.48M	1.87M	547.42K	622.73K	1.21M	850.56K	899.58K	769.08K	1.43M	1.80M	704.85K	413.55K	537.38K	20.00	26.08K	13.12K
Research & Development	1.86M	811.86K	672.21K	60.95K	15.20K	12.80K	-	32.79K	8.66K	327.00K	137.40K	1.83K	142.65K	-	-	-	-
Other Expenses	438.88K	80.40K	12.74K	14.07K	13.77K	-871.73K	-76.93K	60.73K	4.25K	-	-	-	-	-	-	-	-
Operating Expenses	13.12M	10.37M	2.55M	622.44K	651.71K	1.22M	857.19K	993.11K	781.99K	1.76M	1.94M	706.68K	556.20K	537.38K	20.00	26.08K	13.12K
Interest Expense	137.31K	39.41K	328.82K	168.10K	115.90K	159.42K	104.83K	34.73K	307.21K	179.10K	6.46K	1.27K	-	-	-	5.03K	-13.12K
Selling & Marketing Expenses	734.25K	578.09K	-	-	-	-	-	-	-	105.00K	-	-	-	-	20.00	2.00K	-
Cost & Expenses	28.88M	13.02M	2.67M	648.28K	662.76K	1.61M	857.19K	993.11K	781.99K	1.76M	1.94M	706.68K	556.20K	537.38K	20.00	26.08K	13.12K
Income Tax	395.17K	233.30K	328.82K	-1.89M	383.39K	-41.53K	1.29K	2.47M	565.42K	-1.75M	548.95K	-703.39K	556.20K	-	-	31.11K	13.12K
Shares Outstanding (Basic)	12.16K	7.59K	1.31K	866.00	1.76K	15.23K	43.63K	21.24K	1.53K	3.68K	3.01K	2.57K	2.44K	1.53K	23.47K	468.00	468.00
Shares Outstanding (Diluted)	12.16K	7.59K	1.31K	866.00	1.76K	15.23K	43.63K	21.24K	1.53K	3.68K	3.01K	2.57K	2.44K	1.53K	23.47K	468.00	468.00
EPS (Basic)	-370.41	-3.52K	-9.77K	-1.04K	-828.01	-141.54	-23.84	-164.63	-270.44	-526.17	-827.19	-275.68	-228.33	-350.77	-	-66.46	-28.04
EPS (Diluted)	-370.41	-3.52K	-9.77K	-1.04K	-828.01	-141.54	-23.84	-164.63	-270.44	-526.17	-827.19	-275.68	-228.33	-350.77	-	-66.46	-28.04
EBITDA	-3.82M	-26.45M	-12.09M	-2.60M	-948.38K	-1.95M	-928.78K	-932.38K	-1.34M	-9.77K	-555.03K	-4.56K	-556.20K	-537.38K	-1.20M	-26.08K	-13.12K
Depreciation & Amortization	149.15K	25.16K	12.74K	14.07K	13.77K	49.36K	6.63K	60.73K	4.25K	1.75M	1.93M	703.39K	-	-	-	-	-